Asthma

SAN ANTONIO — Symptom patterns in alpha-gal syndrome suggest concurrent diseases such as autoimmune disease and vitamin D deficiency, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Pediatric asthma diagnoses decreased by more than 50% during the first year of the COVID-19 pandemic, according to findings published in Respiratory Research.

Patients with asthma and specific eosinophil and IgE levels experienced greater improvements in exacerbations and FEV1 with dupilumab compared with other biologics, according to a study.

SAN ANTONIO — A high proportion of patients with eosinophilic esophagitis also had simultaneous atopic or allergic comorbid conditions, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — When patients are skeptical about climate change and its impact on their asthma or allergy, communication is still possible, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Following 6 months of dupilumab treatment, 57% of patients with NSAID-exacerbated respiratory disease had higher aspirin tolerance than before treatment, according to study results published in European Respiratory Journal.

SAN ANTONIO — Patients with asthma in an inner-city population had more favorable COVID-19 outcomes than patients who did not have asthma, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — Patients with asthma who used a daily self-assessment with their digital inhalers reported better medication adherence, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Small-airway obstruction, which cannot be seen with conventional X-rays, was observed in a virtual chest X-ray enhanced by phase-contrast imaging, according to study results published in Proceedings of the National Academy of Sciences.

SAN ANTONIO — Patients taking biologics for severe asthma experienced COVID-19 than those who were not taking biologics, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.